Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide (10mg-30mg), Dual-Action Incretin Co-Agonist Engineered Engagement of GIP and GLP-1 Receptors Introduction Engineered Engagement of GIP and GLP-1 Receptors Tirzepatide is a 39-residue synthetic peptide engineered to simultaneously activate two distinct incretin receptors, the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), within a single molecular scaffold
Instead of focusing on rigid rules, a dietitian can help you build sustainable eating patterns that fit your appetite, budget, culture, and daily reality
With the right tools, medical guidance, and lifestyle support, midlife can be a powerful reset for long-term vitality
Originally developed to manage blood sugar in diabetics, these meds have taken the weight loss world by storm
This mutation results in the production of a mutant protein with an elongated polyglutamine region, leading to the accumulation of protein aggregates in neurons, particularly in the basal ganglia and cerebral cortex
Patients losing 12 pounds weekly rarely report significant hollowing, while those losing 34 pounds weekly consistently see changes by month 46 of therapy
US$ 29.01
US$ 24.61
